PD-1 inhibitor: clinical trials recruiting now
3
Recruiting trials
6
Conditions studied
0
US states with sites
1
Countries
Phase breakdown
Early Phase 1 1
Phase 2 1
Not applicable 1
Conditions being studied
| Condition | Trials |
|---|---|
| Lung cancer | 2 |
| Chemotherapy-intolerant | 1 |
| Non Small Cell Lung Cancer | 1 |
| Non-small Cell Lung Cancer (NSCLC) | 1 |
| Pancreatic Cancer Resectable | 1 |
| Pancreatic cancer | 1 |
Recruiting trials involving PD-1 inhibitor
- An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment
- Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer
- PROPHET Study: ctDNA-Guided Personalized Induction Immunochemotherapy for NSCLC
Common questions
How many recruiting trials involve PD-1 inhibitor?
3 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.